Research Paper Volume 15, Issue 17 pp 8712—8728
HNRNPA2B1 is a potential biomarker of breast cancer related to prognosis and immune infiltration
Figure 9. Immune infiltration analysis with HNRNPA2BP1. (A) Examine the correlation between HNRNPA2BP1 and the level of immune cell infiltration in breast cancer based on TIMER database. (B) The correlation analysis with 24 immune cells and HNRNPA2BP1 expression (*P < 0.05; **P < 0.01; ***P < 0.001). (C) The correlation analysis with immunostimulators, immunoinhibitors and MHCs (Red, positive correlation; Blue, negative correlation).